Several listed companies in Shanghai and Shenzhen issued important announcements on December 23. The following is a summary of good news:
Shanghai Junshi Biosciences Co.Ltd(688180) : js001sc injection obtained the acceptance notice of drug clinical trial application
Shanghai Junshi Biosciences Co.Ltd(688180) (688180) announced on December 23 that recently, the company received the acceptance notice approved and issued by the State Food and drug administration, and the clinical trial application of js001sc injection was accepted. Preclinical in vivo pharmacodynamic test showed that js001sc showed significant antitumor effect in animal model by subcutaneous injection.
Apple Flavor & Fragrance Group Co.Ltd(603020) : Tianshun food, a holding subsidiary, plans to apply for listing on the new third board
Apple Flavor & Fragrance Group Co.Ltd(603020) (603020) announced on December 23 that Tianshun (Hangzhou) Food Co., Ltd., the holding subsidiary of the company, plans to apply for listing in the National SME share transfer system.
Jiangsu Hengrui Medicine Co.Ltd(600276) : Notice of approval of drug clinical trial for hrs5685 tablets
Jiangsu Hengrui Medicine Co.Ltd(600276) (600276) it was announced on December 23 that the company’s subsidiary recodi drug hrs5685 tablets obtained the notice of approval for drug clinical trial and will carry out clinical trial in the near future. Hrs5685 can inhibit the replication of human immunodeficiency virus type 1 (HIV-1). It is intended to be used in the treatment of people infected with human immunodeficiency virus type 1 (HIV-1).
Bingshan Refrigeration & Heat Transfer Technologies Co.Ltd(000530) : the company’s products were selected as the single champion products of the manufacturing industry of the Ministry of industry and information technology
Bingshan Refrigeration & Heat Transfer Technologies Co.Ltd(000530) (000530) announced on December 23 that the company’s “industrial and commercial open screw refrigeration unit and refrigeration system” was selected as the Sixth Batch of single champion products in the manufacturing industry.
Jiangsu Lianhuan Pharmaceutical Co.Ltd(600513) : dapoxetine hydrochloride tablets obtained the drug registration certificate
Jiangsu Lianhuan Pharmaceutical Co.Ltd(600513) (600513) announced on December 23 that the company’s drug dapoxetine hydrochloride tablets obtained the drug registration certificate approved and issued by the State Food and drug administration. Dapoxetine hydrochloride tablet is a selective serotonin resorption inhibitor for the treatment of adult male premature ejaculation (PE).
Hunan Jingfeng Pharmaceutical Co.Ltd(000908) : the subsidiary flurbiprofen axetil injection obtained the drug registration approval
Hunan Jingfeng Pharmaceutical Co.Ltd(000908) (000908) it was announced on December 23 that the company’s subsidiary, Pude Kangli, obtained the drug registration approval of the chemical “flurbiprofen axetil injection” approved and issued by the State Food and drug administration. Flurbiprofen axetil injection belongs to non steroidal anti-inflammatory and analgesic drugs. It is clinically used for postoperative and cancer analgesia. It can be used as a substitute for fentanyl, which can effectively control pain without addiction, and has no central inhibitory effect, which is conducive to the postoperative recovery of patients.
Zhejiang Jindun Fans Co.Ltd(300411) : the company resumed work and production on December 23
Zhejiang Jindun Fans Co.Ltd(300411) (300411) announced on December 23 that at present, the company has met the requirements of the implementation opinions on orderly resumption of work and production of industrial enterprises in Shangyu district. After the application of the company and the approval of the local government, the company began to resume work and production in an orderly manner on December 23.
Shanghai Pharmaceuticals Holding Co.Ltd(601607) : Telmisartan Tablets, a subsidiary, passed the conformity evaluation of generic drugs
Shanghai Pharmaceuticals Holding Co.Ltd(601607) (601607) it was announced on December 23 that Telmisartan Tablets of Shandong Xinyi, the holding subsidiary of the company, passed the quality and efficacy consistency evaluation of generic drugs, and the drug is mainly used for the treatment of essential hypertension.
Chengdu Xinzhu Road&Bridge Machinery Co.Ltd(002480) : it is proposed to acquire 51.6% equity of Shengtian new energy and enter the photovoltaic power generation industry
Chengdu Xinzhu Road&Bridge Machinery Co.Ltd(002480) (002480) announced on December 23 that the company plans to acquire 51.6% equity of Shengtian new energy held by the controlling shareholder Sichuan development, enter the photovoltaic power generation industry, lay out green and low-carbon industries and enrich the company’s business types. After the completion of this transaction, Shengtian new energy will become the holding subsidiary of the company.
Tongkun Group Co.Ltd(601233) : the first polyester unit of petrochemical polyester integration project is put into trial production
Tongkun Group Co.Ltd(601233) (601233) it was announced on December 23 that the first polyester unit of Jiatong energy Petrochemical polyester integration project, a wholly-owned subsidiary of the company, was put into trial production.
Shandong Longda Meat Foodstuff Co.Ltd(002726) : it is proposed to invest 1.1 billion yuan in high-end meat products deep processing project and pig slaughtering project
Shandong Longda Meat Foodstuff Co.Ltd(002726) (002726) it was announced on December 23 that the company recently signed the investment agreement for high-end meat products deep processing project of Western China meat products production base and the investment agreement for 1 million pigs slaughtering project in Enyang District, Bazhong City with the people’s Government of Enyang District, Bazhong City. The total investment of the high-end meat products deep processing project of the meat products production base in Western China is planned to be 800 million yuan; The total investment of 1 million pigs slaughtering project in Enyang District, Bazhong City is planned to be about 300 million yuan.
Wetown Electric Group Co.Ltd(688226) : it is proposed to invest 100 million yuan to establish a subsidiary to carry out Cecep Solar Energy Co.Ltd(000591) power supply and other new businesses
Wetown Electric Group Co.Ltd(688226) (688226) announced on December 23 that the company plans to invest 100 million yuan in the establishment of its subsidiary Wetown Electric Group Co.Ltd(688226) Group Power Engineering Co., Ltd. to carry out the construction, operation and maintenance of new energy projects such as Cecep Solar Energy Co.Ltd(000591) power supply, Cecep Solar Energy Co.Ltd(000591) lighting system, distributed photovoltaic power station and wind power generation project; General contracting of power engineering; Installation and construction of power engineering; New businesses such as investment in the power industry.
Sinopec Shandong Taishan Pectroleum Co.Ltd(000554) : signed strategic cooperation agreement with Dongyuan development
Sinopec Shandong Taishan Pectroleum Co.Ltd(000554) (000554) it was announced on December 23 that the company signed a strategic cooperation agreement with Xintai overall urban and Rural Development Group Co., Ltd., Shandong Dongyuan Enterprise Development Group Co., Ltd., Ningyang Economic Development Zone Management Committee and Huaneng Taishan Power Co., Ltd. The cooperation contents include but are not limited to the following aspects: Construction of refueling, gas and hydrogen stations; Build ecological new energy supply station; Build a comprehensive energy adding station for oil, gas and hydrogen electric service; Hydrogen energy application demonstration base, etc.
Zhejiang Conba Pharmaceutical Co.Ltd(600572) : Ginkgo biloba products are proposed to win the bid for centralized volume procurement of inter provincial alliance of Chinese patent medicines
Zhejiang Conba Pharmaceutical Co.Ltd(600572) (600572) announced on December 23 that the company (including its subsidiaries) intends to win the bid for Ginkgo biloba capsules and tablets (collectively referred to as Ginkgo biloba products) to be purchased by the inter provincial alliance of Chinese patent medicines.
Shanghai Pudong Construction Co.Ltd(600284) : the subsidiary won the bid for a number of major engineering projects with a total amount of 1.848 billion yuan
Shanghai Pudong Construction Co.Ltd(600284) (600284) announced on December 23 that recently, the company’s subsidiaries Shanghai Pudong New Area Construction (Group) Co., Ltd. and Shanghai Pudong Road and Bridge (Group) Co., Ltd. won the bid for a number of major engineering projects, with a total bid amount of 1.848 billion yuan.
